Infosys BPM Unveils AI Agents to Revolutionize Finance and Accounting Services
New Agentic AI-powered solution set to redefine accounts payable operations with significant efficiency gains, enhanced accuracy and improved user experience
BENGALURU, India, May 30, 2025 /CNW/ -- Infosys BPM, the business process management arm of Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), today announced the launch of AI agents for invoice processing within its flagship Infosys Accounts Payable on Cloud solution. Powered by Infosys Topaz, the innovation redefines invoice processing by moving from a human-driven, AI-supported model to an autonomous AI-first approach, which ensures greater efficiency and accuracy.
Designed to operate autonomously, the solution leverages AI agents equipped with advanced decision-making capabilities to handle complex business scenarios with precision and speed. Autonomous AI-first approach enables end-to-end workflow management, allowing AI agents to handle dynamic processes, adapt to changing business logic, and perform intricate tasks with minimal human oversight. The new Agentic AI-powered Accounts Payable on Cloud solution aims to boost operational efficiency significantly, enabling businesses to scale quickly and effectively. Powered by Microsoft's AI stack, the solution combines Azure AI Foundry and other LLMs with custom AI agents. The integration of Cognitive Services with Azure's Platform-as-a-Service (PaaS) offerings enables the delivery of scalable, intelligent, and enterprise-ready AI solution.
This solution was developed in close collaboration with Americana Restaurants, the largest out-of-home dining and quick service restaurant operator across the Middle East, North Africa, and Kazakhstan, with more than 2,600 restaurants. Building on the successful deployment of Accounts Payable on Cloud solution for Americana, Infosys BPM is now integrating Agentic AI to make their invoice processing largely autonomous, further enhancing its efficiency and accuracy.
Harsh Bansal, Chief Financial Officer and Chief Growth Officer, Americana Restaurants, said, "At Americana Restaurants, we are committed to leading digital transformation, and as we scale our operations, intelligent automation is key to achieving greater efficiency and agility. With AI-powered Infosys Accounts Payable on Cloud, we have made invoice processing faster, enhanced accuracy, and improved efficiency. The addition of Agentic AI takes this a step further, reducing manual dependencies and bringing more intelligence and autonomy into our invoice processing. We are delighted that we have pioneered this initiative with Infosys and look forward to closely working with Infosys BPM to lead us collectively into a future of smarter and more agile operations."
Stephen Boyle, Global Leader, GSIs, ESIs and Advisories, Microsoft, said, "We commend Infosys BPM for launching Microsoft AI agents within its Accounts Payable on Cloud solution, showcasing AI's ability to streamline complex workflows and enhance critical business operations. This innovation underscores Infosys's transformative potential and sets the stage for intelligent automation to drive future business success."
Anantha Radhakrishnan, CEO & Managing Director, Infosys BPM, said, "With the introduction of Agentic AI into Infosys Accounts Payable on Cloud solution, we are redefining what is possible in the finance and accounting functional domain. By integrating Infosys Topaz with a purpose-built multi-agent framework, along with Microsoft's AI stack, we've developed a solution that is autonomous by design, responsive to change, and built to evolve. This exemplifies our commitment to pioneering innovation and delivering unparalleled business value to enterprises worldwide."
About Infosys
Infosys is a global leader in next-generation digital services and consulting. Over 300,000 of our people work to amplify human potential and create the next opportunity for people, businesses and communities. We enable clients in more than 56 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.
Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.
Safe Harbor
Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the 'safe harbor' under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as Generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2024. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
37 minutes ago
- Cision Canada
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions. As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index. By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines. Matti Shem Tov, Chief Executive Officer, Clarivate, said:"This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond." Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference." The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement. Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas. By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research. Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights. To learn more about this partnership and the solutions now available to CAPES institutions, visit here. Notes to editors According to the most recent Institute for Scientific Information G20 research and innovation scorecard: Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact. Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average. More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average. Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average. About Clarivate Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields. Media contacts: Clarivate Catherine Daniel Director, External Communications – Life Sciences & Healthcare [email protected] CAPES João Mendes Communications [email protected] SOURCE Clarivate Plc
Globe and Mail
9 hours ago
- Globe and Mail
Is Nvidia a Buy?
Nvidia (NASDAQ: NVDA) just delivered another record-breaking quarter, sending its stock up 5% and tying Microsoft as the most valuable publicly traded company by market capitalization, at the time of this writing. Despite the strong results, questions linger as the company faces mounting geopolitical pressure and tariff uncertainty. Let's break down the chipmaker's latest performance and explore what the current challenges mean for long-term investors to determine whether Nvidia is a buy, hold, or sell. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Here are the results from Nvidia's latest blowout quarter For the first quarter of fiscal 2026, Nvidia reported $44.1 billion in revenue, representing a 69% year-over-year increase and a 12% increase from its previous quarter, fiscal Q4 2025. Nvidia's net income totaled $18.8 billion, a 26% increase year over year, despite the company incurring a $4.5 billion charge related to new U.S. export restrictions. As for highlights, the company's data center revenue surged to $39.1 billion in the quarter, representing a 73% increase from the prior year. Management also announced that it will be building factories in the U.S. in partnership with others to produce artificial intelligence (AI) supercomputers, which may alleviate some tariff concerns. Additionally, Nvidia continued to return capital to shareholders, with a modest quarterly dividend of $0.01 per share, and repurchased $14.1 billion worth of shares during the quarter. Notably, the management has spent $40 billion over the past 12 months on share buybacks, decreasing its share count by just 0.8% due to the company's massive $3.4 trillion market capitalization. Tariff twists and turns While Nvidia continues to break records, it encountered the aforementioned geopolitical hiccup during the quarter. On April 9, the U.S. government abruptly required Nvidia to secure a license before shipping H20 chips to China. The problem? H2O was already deeply embedded in the company's go-to-market strategy and had generated $4.6 billion in revenue during the quarter. Nvidia was left holding the bag on $4.5 billion worth of unsellable inventory and was unable to ship an additional $2.5 billion in orders before the restrictions took effect. The China market, once seen as a dependable pillar of growth, now represents a major wildcard for Nvidia. With U.S. firms locked out, Nvidia warned that losing access to this near-$50 billion AI accelerator market would materially benefit foreign competitors. Just after Nvidia released its fiscal Q1 earnings, another twist emerged: A federal court blocked President Donald Trump from using emergency powers to impose broad tariffs. While the decision, which the Trump administration intends to appeal, may ease trade tensions for now, it highlights how quickly trade policy can shift and put the brakes on Nvidia's unparalleled growth. Nvidia's Blackwell is its next growth driver Despite the company's geopolitical headaches, Nvidia continues to innovate. Its Blackwell chips -- designed for massive-scale AI workloads -- are the company's next big breakthrough, according to CEO Jensen Huang. To support its growth, the company launched Blackwell Ultra and Nvidia Dynamo during its latest quarter, designed to power the next generation of reasoning AI models. Huang said: Global demand for Nvidia's AI infrastructure is incredibly strong. AI inference token generation has surged tenfold in just one year, and as AI agents become mainstream, the demand for AI computing will accelerate. Countries around the world are recognizing AI as essential infrastructure -- just like electricity and the internet -- and Nvidia stands at the center of this profound transformation. To support the development of its Blackwell product, Nvidia announced in April that it will build and test these chips in Arizona and its AI supercomputers in Texas. Given the company's tariff concerns, it's an unlikely coincidence that management chose the U.S. as the location for manufacturing its newest product. Looking ahead, management projects $45 billion in revenue for its next quarter, plus or minus 2%. Notably, that outlook includes an $8 billion hit from ongoing H20 restrictions, which will continue to impact gross margins. When excluding the projected $8 billion loss, management believes it will achieve a range of "mid-70%" gross margins later in its fiscal 2026, which would be in line with its 75% gross margin for its previous fiscal year. Is Nvidia a buy, sell, or hold? Given Nvidia stock's meteoric rise, it still trades at a steep 45 times trailing earnings. Yet the company has largely grown into that premium, with a three-year median price-to-earnings ratio of around 63. As a clear leader in the fast-moving world of artificial intelligence, Nvidia continues to break new ground, most recently with its next-generation Blackwell chips and AI supercomputers. For growth-focused investors seeking exposure to transformative AI technology, Nvidia remains a compelling long-term investment, even amid geopolitical risks and an elevated valuation multiple. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor 's total average return is979% — a market-crushing outperformance compared to171%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of May 19, 2025
Globe and Mail
19 hours ago
- Globe and Mail
1 No-Brainer S&P 500 Vanguard ETF to Buy Right Now for Less Than $1,000
The S&P 500 index is, without a doubt, the most closely watched stock market barometer on the planet. It contains some 500 large and profitable businesses listed on U.S. stock exchanges. Combined, they represent about 80% of the entire stock market capitalization. Investors who want exposure to the index don't need to look far to find a compelling exchange-traded fund (ETF) to add to their portfolio. In fact, there's one that deserves some attention. Here's why the Vanguard S&P 500 ETF (NYSEMKT: VOO) is a no-brainer buy for someone who might have less than $1,000 of money to put to work in the stock market. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Instant diversification for your portfolio As mentioned, this ETF contains 500 stocks, so investors gain exposure to all sectors of the economy -- from information technology and financials to materials and real estate. This means there is a diverse range of businesses and industries included in the portfolio. At the end of the day, this ETF can be viewed as a bet on the ongoing ingenuity of the American economy and some of the hottest trends -- and this includes artificial intelligence (AI). Some of the ETF's top positions are in companies like Apple, Microsoft, and Nvidia, all of which are focused on AI-related initiatives to fortify their competitive positions. The ETF's sponsor, Vanguard, is one of the most highly regarded asset management firms in the industry. It's been around since 1975. As of the end of last year, it had eclipsed $10 trillion in assets under management, which goes to show you the amount of trust that so many investors (and so much capital) have in the business. The numbers are hard to ignore Warren Buffett, who has an unbelievable track record handling capital allocation and running Berkshire Hathaway, suggests that a low-cost ETF like the Vanguard S&P 500 ETF is the best investment option for most people out there. It's hard to beat an expense ratio of just 0.03%. That's pennies compared to the exorbitant fees you see active fund managers charge. A typical hedge fund charges its clients both a management fee and a performance fee. This can significantly eat away at returns over time. Even so, a good chunk of these so-called experts struggles to outperform the S&P 500 over long stretches of time. Because the S&P 500 has put up better returns than its historical average of 10% per year, it's no wonder the professionals are having a hard time. Just in the past decade, the Vanguard S&P 500 ETF has generated a total return of 232%, which would've turned a $1,000 initial investment into $3,300 today. It's all about mindset Even though the Vanguard S&P 500 ETF has produced such a great return, it doesn't necessarily mean that investors have achieved that same performance in their own portfolios. It's easy to fall victim to our emotions, with the goal of successfully trying to time the market, forcing us to trade too frequently, resulting in more damage being done. This is why it's critical to fixate on the next decade and beyond with your investments instead of the next month or year. The stock market rewards those who are patient and disciplined, even in the face of extreme bouts of volatility, like what we experienced earlier in 2025. It's impossible to say whether or not the Vanguard S&P 500 ETF will repeat its past decade's performance between now and 2035. However, I'm sure that long-term investors will end up with a very favorable result. Should you invest $1,000 in Vanguard S&P 500 ETF right now? Before you buy stock in Vanguard S&P 500 ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard S&P 500 ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor 's total average return is979% — a market-crushing outperformance compared to171%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Neil Patel has positions in Vanguard S&P 500 ETF. The Motley Fool has positions in and recommends Apple, Berkshire Hathaway, Microsoft, Nvidia, and Vanguard S&P 500 ETF. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
